Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
5.80
+0.51 (9.64%)
At close: Nov 3, 2026, 4:00 PM EST
5.41
-0.39 (-6.72%)
After-hours: Nov 3, 2026, 7:59 PM EST

Aethlon Medical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
4374922
Market Cap Growth
194.61%-53.53%68.01%-49.90%-60.95%-8.57%
Enterprise Value
-0-33-3-72
Last Close Price
5.8010.95143.20672.001530.005840.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-4.574.574.574.57-
PS Ratio
----15.3076.47
PB Ratio
0.530.701.440.760.581.32
P/TBV Ratio
0.790.701.440.760.581.31

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
-----7.82

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.070.110.160.160.080.04
Net Debt / Equity Ratio
-0.88-0.92-0.91-0.78-0.88-0.96
Net Debt / EBITDA Ratio
0.680.650.520.371.141.59
Net Debt / FCF Ratio
0.640.640.610.431.161.62
Asset Turnover
----0.030.02
Quick Ratio
4.763.472.902.979.669.43
Current Ratio
5.423.853.133.4010.039.95
Return on Equity (ROE)
-160.91%-142.89%-245.88%-117.21%-75.06%-79.29%
Return on Assets (ROA)
-76.69%-66.58%-74.82%-61.33%-40.28%-43.30%
Return on Capital Employed (ROCE)
-136.20%-149.30%-171.10%-197.00%-74.30%-59.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-542.26%-208.11%-181.04%-277.36%-136.93%-46.30%
FCF Yield
-174.39%-203.77%-103.39%-235.84%-130.31%-44.97%
Buyback Yield / Dilution
-497.17%-331.78%----
SEC Filings: 10-K · 10-Q